DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer

被引：0
|
作者：
Varun Sasidharan Nair
Salman M. Toor
Rowaida Z. Taha
Hibah Shaath
Eyad Elkord
机构：
[1] Qatar Foundation,Cancer Research Center, Qatar Biomedical Research Institute, College of Science and Engineering, Hamad Bin Khalifa University
[2] Institute of Cancer Sciences,undefined
[3] University of Manchester,undefined
来源：
Clinical Epigenetics | 2018年 / 10卷
关键词：
Colorectal cancer; Immune checkpoints; PD-L1; Galectin-9; DNA methylation; Histone trimethylation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
    Nakayama, Chieri
    Tanoue, Kiyonori
    Idichi, Tetsuya
    Shimomura, Hiroki
    Kita, Yoshiaki
    Hozaka, Yuto
    Shinden, Yoshiaki
    Matsushita, Daisuke
    Nakajo, Akihiro
    Arigami, Takaaki
    Mataki, Yuko
    Kurahara, Hiroshi
    Ohtsuka, Takao
    ANTICANCER RESEARCH, 2022, 42 (07) : 3373 - 3380
  • [42] The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
    Kreidieh, Firas Y.
    Tawbi, Hussein A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [43] The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition
    Kreidieh, Firas Y.
    Tawbi, Hussein A.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [44] Expression of inhibitory receptors PD-1, CTLA-4, and Tim-3 by peripheral T cells during pregnancy
    Smetanenko, E. A.
    Khonina, N. A.
    Leplina, O. Yu.
    Tikhonova, M. A.
    Batorov, E. V.
    Pasman, N. M.
    Chernykh, E. R.
    BYULLETEN SIBIRSKOY MEDITSINY, 2022, 21 (03): : 87 - 95
  • [45] Roles of PD-1, Tim-3 and CTLA-4 in immunoregulation in regulatory T cells among patients with sepsis
    Gao, Dong-Na
    Yang, Zhi-Xiang
    Qi, Qing-Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18998 - 19005
  • [46] Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
    S A Quezada
    K S Peggs
    British Journal of Cancer, 2013, 108 : 1560 - 1565
  • [47] PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma
    de Vos, Luka
    Dietrich, Joern
    Strieth, Sebastian
    Bootz, Friedrich
    Dietrich, Dimo
    Franzen, Alina
    IMMUNOTHERAPY, 2020, 12 (12) : 903 - 920
  • [48] Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
    Quezada, S. A.
    Peggs, K. S.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1560 - 1565
  • [49] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis
    Jin, Chunhui
    Zhu, Xiaodan
    Huang, Xiaona
    Gong, Tingjie
    Wei, Zhipeng
    You, Jianliang
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (03) : 203 - 212
  • [50] PD-1, TIM-3, and LAG-3 Expression in T Cells in a Patient with Recurrent Ossifying Fibroma: A Case Report
    Garcia-Munoz, Alejandro
    Goreti Nieto-Velazquez, Nayeli
    Damian-Morales, Gabriela
    Liceaga-Escalera, Carlos
    Alberto Montoya-Perez, Luis
    Cruz-Velez, Madeleine
    Antonio Gomez-Hernandez, Pabel
    Trejo-Iriarte, Cynthia
    Pastelin-Palacios, Rodolfo
    Adan Moreno-Eutimio, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2020, 9 (04) : 307 - 311
12345